Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-14

Clinical Trial Update: Topical Timolol for Infantile Hemangioma in Early Proliferative Phase [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating topical timolol for infantile hemangioma in the early proliferative phase has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical timolol (timolol)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Hemangioma | Phase 2 | Status: COMPLETED